| 标题 |
Firmonertinib 160mg in EGFR-Mutated NSCLC with Brain Metastases After EGFR-TKI Resistance (iFORCE): Clinical Outcomes and Mechanistic Insights |
| 网址 | |
| DOI |
10.1093/neuonc/noag260
doi
|
| 其它 |
期刊:Neuro-Oncology 作者:Mengxing You; Tongji Xie; Lige Wu; Jiayu Liu; Yan Li; et al 出版日期:2026-10-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)